These Adverse Events Linked to Improved Cancer Prognosis
Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.
Zhong Da Fei Wang Postgraduate Research Southeast University School Of Medicine Practice Innovation Program Of Jiangsu Province
Source: medscape.com